Vivimed Labs Ltd

VIVIMEDLAB

Watchlist

AI Mode

‌

Market Cap

₹ 220 Cr

P/E

—

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

LOW MARGIN

Technicals

—

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

220 Cr

Volatility

—

P/E Ratio

—

Industry P/E

30.6

PEG Ratio

—

P/B Ratio

—

52W High

27.99

52W Low

26.51

Sales CAGR

-22.00%

-21.16%

-35.71%

10Y

-23.82%

Profit CAGR

29.68%

—

10Y

—

ROE

TTM

50.81%

33604.55%

-68.64%

10Y

-4.32%

ROCE

TTM

-2.49%

-22.60%

-11.78%

10Y

3.61%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
LYKALABS	75.07	268 Cr	131.70	2.65	0.00	2.03	4.68	1.50
VIVIMEDLAB	26.51	220 Cr	—	0.00	0.00	50.81	-2.49	-2.64
AMBASARABH	27.30	209 Cr	13.38	1.42	0.00	10.60	10.22	3.70
SYSCHEM	47.45	208 Cr	46.06	2.20	0.00	4.78	5.68	2.49
NATCAPSUQ	174.60	180 Cr	—	0.80	0.00	-4.87	-1.11	-2.84
ALPA	76.51	161 Cr	8.63	0.88	0.00	10.18	12.57	7.85
BALAXI	28.11	155 Cr	10.69	0.65	0.00	6.09	7.48	4.50

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	35	34	41	39	29	25	37	26	21	21
Expenses	36	40	40	67	40	25	35	28	22	22
Operating Profit	-0.33	-5.91	1.27	-28	-11	-0.64	1.06	-2.47	-0.28	-0.96
OPM %	-0.93	-17.57	3.06	-73.69	-37.45	-2.58	2.90	-9.64	-1.31	-4.66
Other Income	0.11	2.20	0.04	7.63	0.06	0.03	0.07	4.22	0.38	0.21
Interest	11	12	13	-33	0.30	0.43	0.48	1.74	0.58	1.66
Depreciation	4.70	4.70	4.70	5.84	4.01	4.10	6.62	5.50	5.01	4.90
Profit Before Tax	-16	-20	-17	6.65	-15	-5.14	-5.98	-5.49	-5.49	-7.30
Tax %	0.00	0.00	3.31	20.90	0.00	0.00	0.00	-2.00	0.00	0.00
Net Profit	-16	-20	-16	5.26	-15	-5.14	-5.98	-5.60	-5.49	-7.30
EPS in Rs	—	—	—	—	—	—	—	—	—	—

Consolidated Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	1,346	1,462	1,186	1,315	1,059	861	237	187	149	116
Expenses	1,114	1,059	974	1,138	1,051	832	245	374	182	129
Operating Profit	232	403	212	177	8.11	30	-8.06	-187	-33	-13
OPM %	17.25	27.54	17.88	13.47	0.77	3.45	-3.40	-100.11	-22.42	-11.22
Other Income	11	8.09	9.61	23	8.26	9.82	1.27	0.97	9.98	4.37
Interest	82	66	79	67	59	54	40	36	2.43	2.95
Depreciation	61	58	56	67	67	55	18	108	20	20
Profit Before Tax	100	286	86	66	-109	-70	-65	-331	-46	-32
Tax %	16.27	25.31	11.22	13.14	0.33	-2.90	-4.35	0.64	0.82	-0.35
Net Profit	84	214	76	57	-109	-72	-68	-329	-45	-32
EPS in Rs	—	—	—	—	—	—	—	—	—	—
Dividend Payout %	0.00	1.54	4.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	17	17	17	17	17	17	17	17
Reserves	505	718	1,210	927	818	415	348	23	-22	-52
Borrowings	729	835	710	757	889	326	359	379	377	376
Other Liabilities	793	493	457	628	486	532	543	577	579	580
Total Liabilities	2,044	2,062	2,394	2,329	2,210	1,289	1,266	995	951	921
Fixed Assets	814	879	1,035	965	1,045	502	520	436	418	408
CWIP	94	76	65	122	89	60	40	21	21	17
Investments	2.69	2.71	2.70	2.51	86	199	199	199	168	168
Other Assets	1,133	1,104	1,290	1,239	990	529	507	340	344	328
Total Assets	2,044	2,062	2,394	2,329	2,210	1,289	1,266	995	951	921

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	154	58	21	422	80	567	28	35	-24	-1.75
Cash from Investing Activity	-190	-68	-164	-89	-196	404	-16	-4.96	28	-4.53
Cash from Financing Activity	41	35	186	-338	72	-1,015	-10	-34	-6.03	4.96
Net Cash Flow	4.29	25	44	-4.53	-44	-44	0.75	-3.42	-1.74	-1.32

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	20.96%	20.94%	20.94%	20.94%	20.94%	20.94%	20.94%	20.94%	20.94%	20.94%	7.77%	7.77%
FIIs	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%	1.64%
DIIs	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%
Public	77.28%	77.30%	77.30%	77.30%	77.30%	77.30%	77.30%	77.30%	77.30%	77.30%	90.48%	90.48%
Total Shareholders	51,026	50,683	49,503	49,038	49,027	49,016	49,012	49,003	49,005	48,957	48,928	48,925

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Mar 20, 2023	Santosh varalwar	Insider - Promoter & Director	Invoke	2.00	0.00 Cr	12,854	0.01

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	35	34	41	39	29	25	37	26	21	21
Expenses	36	40	40	67	40	25	35	28	22	22
Operating Profit	-0.33	-5.91	1.27	-28	-11	-0.64	1.06	-2.47	-0.28	-0.96
OPM %	-0.93	-17.57	3.06	-73.69	-37.45	-2.58	2.90	-9.64	-1.31	-4.66
Other Income	0.11	2.20	0.04	7.63	0.06	0.03	0.07	4.22	0.38	0.21
Interest	11	12	13	-33	0.30	0.43	0.48	1.74	0.58	1.66
Depreciation	4.70	4.70	4.70	5.84	4.01	4.10	6.62	5.50	5.01	4.90
Profit Before Tax	-16	-20	-17	6.65	-15	-5.14	-5.98	-5.49	-5.49	-7.30
Tax %	0.00	0.00	3.31	20.90	0.00	0.00	0.00	-2.00	0.00	0.00
Net Profit	-16	-20	-16	5.26	-15	-5.14	-5.98	-5.60	-5.49	-7.30
EPS in Rs	—	—	—	—	—	—	—	—	—	—

Consolidated Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	1,346	1,462	1,186	1,315	1,059	861	237	187	149	116
Expenses	1,114	1,059	974	1,138	1,051	832	245	374	182	129
Operating Profit	232	403	212	177	8.11	30	-8.06	-187	-33	-13
OPM %	17.25	27.54	17.88	13.47	0.77	3.45	-3.40	-100.11	-22.42	-11.22
Other Income	11	8.09	9.61	23	8.26	9.82	1.27	0.97	9.98	4.37
Interest	82	66	79	67	59	54	40	36	2.43	2.95
Depreciation	61	58	56	67	67	55	18	108	20	20
Profit Before Tax	100	286	86	66	-109	-70	-65	-331	-46	-32
Tax %	16.27	25.31	11.22	13.14	0.33	-2.90	-4.35	0.64	0.82	-0.35
Net Profit	84	214	76	57	-109	-72	-68	-329	-45	-32
EPS in Rs	—	—	—	—	—	—	—	—	—	—
Dividend Payout %	0.00	1.54	4.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	17	17	17	17	17	17	17	17
Reserves	505	718	1,210	927	818	415	348	23	-22	-52
Borrowings	729	835	710	757	889	326	359	379	377	376
Other Liabilities	793	493	457	628	486	532	543	577	579	580
Total Liabilities	2,044	2,062	2,394	2,329	2,210	1,289	1,266	995	951	921
Fixed Assets	814	879	1,035	965	1,045	502	520	436	418	408
CWIP	94	76	65	122	89	60	40	21	21	17
Investments	2.69	2.71	2.70	2.51	86	199	199	199	168	168
Other Assets	1,133	1,104	1,290	1,239	990	529	507	340	344	328
Total Assets	2,044	2,062	2,394	2,329	2,210	1,289	1,266	995	951	921

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	154	58	21	422	80	567	28	35	-24	-1.75
Cash from Investing Activity	-190	-68	-164	-89	-196	404	-16	-4.96	28	-4.53
Cash from Financing Activity	41	35	186	-338	72	-1,015	-10	-34	-6.03	4.96
Net Cash Flow	4.29	25	44	-4.53	-44	-44	0.75	-3.42	-1.74	-1.32

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
LYKALABS	75.07	268 Cr	131.70	2.65	0.00	2.03	4.68	1.50
VIVIMEDLAB	26.51	220 Cr	—	0.00	0.00	50.81	-2.49	-2.64
AMBASARABH	27.30	209 Cr	13.38	1.42	0.00	10.60	10.22	3.70
SYSCHEM	47.45	208 Cr	46.06	2.20	0.00	4.78	5.68	2.49
NATCAPSUQ	174.60	180 Cr	—	0.80	0.00	-4.87	-1.11	-2.84
ALPA	76.51	161 Cr	8.63	0.88	0.00	10.18	12.57	7.85
BALAXI	28.11	155 Cr	10.69	0.65	0.00	6.09	7.48	4.50

Overview

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

220 Cr

Volatility

—

P/E Ratio

—

Industry P/E

30.6

PEG Ratio

—

P/B Ratio

—

52W High

27.99

52W Low

26.51

Sales CAGR

-22.00%

-21.16%

-35.71%

10Y

-23.82%

Profit CAGR

29.68%

—

10Y

—

ROE

TTM

50.81%

33604.55%

-68.64%

10Y

-4.32%

ROCE

TTM

-2.49%

-22.60%

-11.78%

10Y

3.61%

Vivimed Labs Ltd

Vivimed Labs Ltd

VIVIMEDLAB

AI Mode

Investment Checklist

Investment Checklist

Overview

Sector

Industry

Market Cap

Volatility

P/E Ratio

Industry P/E

PEG Ratio

P/B Ratio

52W High

52W Low

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Projection

Actions

Announcements

Documents

AI Mode

AI Mode

Technicals

Financial Statements

AI Powered Summary

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Peers

Price Chart Comparison

Overview

Sector

Industry

Market Cap

Volatility

P/E Ratio

Industry P/E

PEG Ratio

P/B Ratio

52W High

52W Low

Investment Checklist

Announcements